NEJM
"CONCLUSIONS
Early autologous stem-cell transplantation improved progression-free survival among patients with high-intermediate-risk or high-risk disease who had a response to induction therapy. Overall survival after transplantation was not improved, probably because of the effectiveness of salvage transplantation."
http://www.nejm.org/doi/full/10.1056/NEJMoa1301077
http://www.nejm.org/doi/full/10.1056/NEJMoa1301077
No comments:
Post a Comment